How Bausch + Lomb is Safely Returning enVista® IOLs to the Market Weeks after TASS Recall #12

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from How Bausch + Lomb is Safely Returning enVista® IOLs to the Market Weeks after TASS Recall #12

Paradigm-Shifting Innovation Headlines Day 2 at ASCRS 2025 #8

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Paradigm-Shifting Innovation Headlines Day 2 at ASCRS 2025 #8

Two Rival Treatments Approved for Geographic Atrophy Under the Spotlight #2

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from Two Rival Treatments Approved for Geographic Atrophy Under the Spotlight #2

A History of Discovery: Why AbbVie Focuses on Challenging Eye Care Diseases #4

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed non risus. Suspendisse lectus tortor, dignissim sit amet, adipiscing nec, ultricies sed, dolor. Cras elementum ultrices diam. Maecenas ligula massa, varius a, semper congue, euismod non, mi. Proin porttitor, orci nec nonummy molestie, enim est eleifend mi, non fermentum diam nisl sit amet erat. Duis semper. […]

Read More… from A History of Discovery: Why AbbVie Focuses on Challenging Eye Care Diseases #4